Irinotecan

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

61 API Suppliers, 32 USDMF, 12 CEP/COS, 9 JDMF, 7 EU WC, 13 KDMF, 12 NDC API, 35 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

70 Drugs in Development

70 Drugs in Development

INTERMEDIATES

19 API Suppliers

19 API Suppliers

FINISHED DOSAGE FORMULATIONS

217 FDF Dossiers, 65 FDA Orange Book, 93 Europe, 7 Canada, 14 Australia, 16 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/5ML (20MG/ML), INJECTABLE;INJECTION - 300MG/15ML (20MG/ML), INJECTABLE;INJECTION - 40MG/2ML (20MG/ML), INJECTABLE, LIPOSOMAL;INTRAVENOUS - EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 4 Nippon Fine Chemical, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 3 Actylis, 1 BioSpectra, 11 Roquette, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

9 Film Formers & Plasticizers, 7 Parenteral, 4 Fillers, Diluents & Binders, 4 Taste Masking, 4 Coating Systems & Additives, 3 Surfactant & Foaming Agents, 2 Chewable & Orodispersible Aids, 2 Emulsifying Agents, 2 Topical, 2 Co-Processed Excipients, 1 Soft Gelatin, 1 Direct Compression, 1 Thickeners and Stabilizers, 1 Solubilizers, 1 Dry Powder Inhalation